Envisages development of novel diagnostics and vaccines for Covid-19
Mysore/Mysuru: As part of various initiatives towards mitigating
Covid-19, the city-based CSIR-Central Food Technological Research Institute (CSIR-CFTRI) recently signed a Memorandum of Understanding (MoU) with Clevergene, a Bengaluru-based company, for sequencing of the SARS-CoV-2 genome.
It is expected that the study would provide insights into virus genome changes (mutations), evolution, epidemiology, and provide an understanding of the spatial and temporal information on infection dynamics of the SARS-CoV-2.
Further, under the MoU, the development of novel diagnostics and vaccines for Covid-19 are envisaged. CSIR-CFTRI has also established a COVID Testing Centre in Mysuru, and on an average, more than 1,000 samples are tested in a day.